Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Part of paid clinical trials in Santa Monica, California.

Sponsor
Tracon Pharmaceuticals Inc.
Study ID
NCT02354612
Status
No Longer Available

Conditions

  • Solid Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TRC105 — DRUG
  • Bevacizumab — DRUG
    companion therapy selection depends on companion therapy used in the parent study
  • Axitinib — DRUG
    companion therapy selection depends on companion therapy used in the parent study
  • Pazopanib — DRUG
    companion therapy selection depends on companion therapy used in the parent study
  • Capecitabine — DRUG
    companion therapy selection depends on companion therapy used in the parent study

Study Details

Open-label, continuation study

Key Dates

First listed
Feb 3, 2015
Status verified
Jan 2021

Locations (1)

FacilityCityStateZIPSite coordinators
UCLASanta MonicaCalifornia90404-

Find similar trials in Santa Monica, CA

By research site
UCLA· Santa Monica, CA

Related Studies